Employees are the basis of any company’s success. Without them, you won’t prosper in any location, and they are especially critical to ensure a prosperous offshore operation. Working for a business that values the employee creates benefit for both parties and can equate to significant monetary value.
Innovation can often upset the apple cart, especially in cases where new and unfamiliar technologies are utilized to enable new functionality. This less-than-optimal user experience can hurt the product’s adoption and lead to high rates of abandonment. Here are five suggestions to ensure that new designs lead to safe, effective, and desirable outcomes.
The first part of this article examined how China’s healthcare reform, within the context of the 13th Five-Year Plan, affected Chinese diagnostic imaging vendors. Here, we examine the role of foreign manufacturers, as well as the challenges and opportunities they face.
China's course toward national development has placed healthcare reform front and center. An expanding middle class — with expanding global connectivity — is increasingly demanding congruency with Western healthcare standards. This two-part article outlines key challenges and opportunities resultant of China’s 13th Five-Year Plan and healthcare reform, starting with a look at domestic systems' place in the imaging market.
The orthopedic implant industry is in a continual state of development, witnessing an explosion of novel materials, designs, and applications. This process is, however, often laced with challenges and articulating joints can present the greatest number of these. By Aia Malik, Lucideon, and Chris Pickles, Ph.D.
Fused Deposition Modeling™ (FDM® ) can be used to produce an array of medical devices; however, for such devices to be practical, they must be manufactured using sterilizable materials. By David Espalin, Francisco Medina, Mireya Perez, and Ryan Wicker, The University of Texas at El Paso; and Terry Hoppe and Rob Winker, Stratasys
Manufacturing Execution System (MES) solutions have the potential to generate efficiencies, improve productivity, and simplify compliance within the medical device manufacturing industry. Used to manage production activities, this class of software typically provides the ability to schedule activity, deliver instructions to operators, synchronize manual activities with automated processes, and integrate with manufacturing computer systems to enable quality control, deviation management and effective enterprise resource planning (ERP), equipment management, and the documenting of floor activities for monitoring and reporting purposes.
The complexities of implantable medical devices such as stents, intraocular lenses, prosthetics, and catheters have increased dramatically to meet new usage demands and improve patient outcomes. The advanced features and materials used for the fabrication of these devices has proven to be a challenge. As stent-strut sizes continue to shrink and the quality of cut edges becomes more critical, the degree of precision needed is more difficult to achieve. Ultrashort-pulse lasers are on their way to becoming the tool of choice for creating these medical devices with high precision. This article discusses the technology behind ultrashort-pulse lasers and how they are used in the process of micromachining ultrafine stents, bioabsorbable stents, and many other devices.
There’s a need for better access to medical technology in the region — a forward-looking approach will help companies reach more patients.
Toyota announced a strategic partnership with Segway inventor Dean Kamen and his company Deka Research and Development to develop the next-generation iBot, a motorized wheelchair capable of self-balancing and climbing stairs. The deal will give Toyota access to Deka’s proprietary balancing technology while providing Deka with the necessary funds to launch iBot and other potential collaborative projects.
Varian Medical Systems plans to spin off its imaging components business into a new independent, publicly traded company with projected annual revenues of $574 million and 1,300 employees worldwide. The move will allow Varian to concentrate on its radiation oncology business.
The US Food and Drug Administration (FDA) has issued final guidance for manufacturers subject to postmarket surveillance requirements of certain Class II and Class III medical devices under Section 522 of the US Federal Food, Drug and Cosmetic Act (the Act), as amended by Section 212 of the Food and Drug Modernization Act (FDAMA) of 1997, and Section 212 of the Food and Drug Modernization Act (FDAMA) of 1997.
The National Institute on Alcohol Abuse and Alcoholism (NIAAA), an arm of the National Institute of Health (NIH), has awarded a $200,000 prize to San Francisco-based startup BACtrack for its wristband that monitors blood alcohol concentration (BAC) in sweat. The developers say the device could aid alcoholism research and treatment.
Ken Reali, president and CEO of Clinical Innovations, LLC, recently was honored with the inaugural PwC Award for Small Company Compliance Achievement in the MedTech Industry at the ninth annual Global MedTech Compliance Conference (GMTCC) in Dublin, Ireland.
Royal Philips announced recently an eight-year, $36 million deal to provide patient monitoring services for Medical University of South Carolina Health (MUSC Health). It's Philips' fifth, long-term, strategic deal with a North American hospital.
Stanford University scientists have developed a technology that could make the rapid urine tests frequently used in the doctors’ offices more reliable and accurate for at-home use. By addressing the most common human errors in dipstick testing — timing, volume of sample, and lighting — the technology could deliver faster test results to patients and reduce the burden on overextended medical laboratories and primary care doctors.
BALT's president, Nicolas Plowiecki, and the Board of Directors has recently hired Pascal Girin, a veteran of Medical Devices market, as the new CEO of BALT International. BALT will continue to focus on accompanying practitioners through further innovation to treat complex life-threatening conditions. The appointment of Pascal is meant to bolster the commercial and market access capabilities of Balt and lead its expansion in the US market.